Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines.
Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines.
复制标题
DOI:
10.1021/jm100478y
复制
发表时间:
2010-08-12
影响因子:
7.3
通讯作者:
Jin J
中科院分区:
文献类型:
--
作者:
Liu F;Chen X;Allali-Hassani A;Quinn AM;Wigle TJ;Wasney GA;Dong A;Senisterra G;Chau I;Siarheyeva A;Norris JL;Kireev DB;Jadhav A;Herold JM;Janzen WP;Arrowsmith CH;Frye SV;Brown PJ;Simeonov A;Vedadi M;Jin J
Protein lysine methyltransferase G9a, which catalyzes methylation of lysine 9 of histone H3 (H3K9) and lysine 373 (K373) of p53, is over expressed in human cancers. Genetic knockdown of G9a inhibits cancer cell growth and the di-methylation of p53 K373 results in the inactivation of p53. Initial SAR exploration of the 2,4-diamino-6,7-dimethoxyquinazoline template represented by 3a (BIX01294), a selective small molecule inhibitor of G9a and GLP, led to the discovery of 10 (UNC0224) as a potent G9a inhibitor with excellent selectivity. A high resolution X-ray crystal structure of the G9a-10 complex, the first co-crystal structure of G9a with a small molecule inhibitor, was obtained. Based on the structural insights revealed by this co-crystal structure, optimization of the 7-dimethylaminopropoxy side chain of 10 resulted in the discovery of 29 (UNC0321) (Morrison Ki = 63 pM), which is the first G9a inhibitor with picomolar potency and the most potent G9a inhibitor to date.
登录
查看更多内容
影响因子:
3.7
作者:
Kondo Y;Shen L;Ahmed S;Boumber Y;Sekido Y;Haddad BR;Issa JP
通讯作者:
Issa JP
影响因子:
4.8
作者:
Li, Yan;Reddy, Marpadga A.;Natarajan, Rama
通讯作者:
Natarajan, Rama
影响因子:
16
作者:
Kubicek, Stefan;O'Sullivan, Roderick J.;Jenuwein, Thomas
通讯作者:
Jenuwein, Thomas
影响因子:
--
作者:
Quinn AM;Allali-Hassani A;Vedadi M;Simeonov A
通讯作者:
Simeonov A
影响因子:
2.9
作者:
Collazo, E;Couture, JF;Trievel, RC
通讯作者:
Trievel, RC